Bottom line
IDNA vs SWHFX: the short answer
IDNA (iShares Genomics Immunology and Healthcare ETF) and SWHFX (Schwab Health Care Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
IDNA is cheaper at 0.47% vs 0.8% — a difference of $33 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs −4.8% for IDNA (reporting dates differ).
Updated Nov 19, 2026
IDNA vs SWHFX side by side
| IDNA | SWHFX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.47% | 0.8% |
| Annual cost per $10k | $47 | $80 |
| 10-yr cost on $10k (prospectus) | $591 | $990 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −1.0% | +15.9% |
| 5-yr return (annualized) | −4.8% | +6.5% |
| 10-yr return (annualized) | — | +8.1% |
| Best quarter | +41.9% | +15.3% |
| Worst quarter | −21.5% | −12.1% |
| Net assets (fund) | $190.9M | $642.3M |
| Number of holdings | 61 | 80 |
| Portfolio turnover | 49% | 41% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDNA | SWHFX | Difference |
|---|---|---|---|
| 2024 | −1.0% | +0.1% | −1.1% |
| 2023 | −7.8% | +0.7% | −8.4% |
| 2022 | −42.1% | −4.7% | −37.4% |
| 2021 | −4.0% | +23.3% | −27.3% |
| 2020 | +54.5% | +12.9% | +41.6% |
Source: Fund prospectus bar charts
Holdings overlap
7 of IDNA's top 25 holdings also appear in SWHFX's top 25.
| Holding | IDNA | SWHFX |
|---|---|---|
| Incyte Corporation | 4.23% | 1.37% |
| Merck & Co., Inc. | 3.91% | 4.98% |
| Vertex Pharmaceuticals Incorporated | 3.87% | 1.89% |
| Roche Holding AG | 3.85% | 2.29% |
| Ipsen Sa | 3.84% | 1.34% |
| Gsk Plc | 3.63% | 1.73% |
| Sanofi Sa | 3.46% | 1.31% |
Source: SEC Form N-PORT
IDNA top 10
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Regeneron Pharmaceuticals, Inc. — 4.35%
- Genmab A/s — 4.23%
- Incyte Corporation — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- Merck & Co., Inc. — 3.91%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between IDNA and SWHFX?
Which is cheaper, IDNA or SWHFX?
Should I own both IDNA and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.